玖玖国产伊人,福利精品熟女视频

Top 10 Diabetes Medications to Watch in 2024 Diabetes Discover the top 10 diabetes medications of 2024, including Ozempic, Jardiance, and Mounjaro. Learn about their sales, innovations, and why they're leading in the treatment of diabetes and related conditions.
Merck: Termination of Two Oncology Projects Merck Merck announces the termination of two oncology projects: Vibostolimab (anti-TIGIT) and Favezelimab (anti-LAG-3), citing safety concerns and failure to meet clinical endpoints in key trials.
MK-3475A-D77 Study Success Merck Merck's Phase III MK-3475A-D77 study shows positive results for subcutaneous pembrolizumab (MK-3475A) compared to intravenous Keytruda, improving patient experience and accessibility for metastatic NSCLC treatment.
$1.3 Billion! Merck Acquires a Biotech Company Merck Merck has acquired Modifi Biosciences for up to $1.3 billion, securing rights to its experimental cancer therapy, KL-50, aimed at treating hard-to-treat brain tumors like gliomas. This deal includes a $30 million upfront payment, with potential milestone payments.
MNC Profiles: Who Values ??the Chinese Market Most? AstraZeneca Explore the competitive landscape of multinational pharmaceutical companies (MNCs) in China’s booming healthcare market. Delves into MNC revenue trends, strategies, and insights, highlighting which companies value the Chinese market most.
South Korean Couple Builds $100 Billion Pharmaceutical Company, Signs Major Deal with Merck Merck In April 2024, South Korean biopharmaceutical company Alteogen co-founded by Dr. Park Soon-jae, secured a $100 billion valuation after partnering with Merck for its recombinant human hyaluronidase technology.
Merck's First-Quarter 2024 Financial statements Financial statements Merck published its Q1 2024 financial statements on April 25, 2024.

< Pre 1 23Next>

Articles Archives

Hot Articles

All Categories

Agri & Industry Cosmetic Laboratory Pharmaceutical Food

国产91视频久久,亚洲综合色图在线观看,五月天操逼网,日韩色色AV,青青在线A片,亚洲最大色在线观看,欧美熟妇丝袜诱惑,青青操逼视频,日韩无码操出水